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Background: Based on current guidelines, ticagrelor/prasugrel
are preferred over clopidogrel in myocardial infarction (Ml) treated
with percutaneous coronary intervention (PCI) and drug eluting
stent (DES). In Malaysia, clopidogrel is still the most commonly used
ADP antagonist. The role of routine platelet function testing (PFT)
with point of care instruments (POC) has not been established.
Objective: To examine the clinical and economic impact of a
novel POC-guided antiplatelet strategy in patients with Ml and DES.
Methods: At a tertiary referral centre, patients admitted be-
tween Sep-Dec 2017 with Ml, treated with DES, underwent PFTs
with Multiplate (Roche, Switzerland) and CYP2C19 genotyping
with Spartan Rx (Spartan Bioscience, Canada). Patients showing
high on-treatment platelet reactivity (HPR) were switched from
clopidogrel to ticagrelor. One-month follow-up and cost-analysis
were performed.
Results: We recruited 41 patients (STEMI: 46.3%; NSTEMI:
53.7%), mean age 56.63±11.75 years and 92.7% males. Approxi-
mately one-third had wild type (WT) CYP2C19 *1/*1 genotype,
while the remaining had ≥ 1 loss-of-function alleles (LOF) [(WT:
29.3%; 1LOF: 61.0%; 2LOF: 9.8%); (Percentage of clopidogrel HPR:
0%, 8%, 25% respectively)]. None had *17 gain-of-function alleles.
Clopidogrel reactivity (MEA ADP) was significantly higher in
patients with more LOF compared to WT [median (IQR): WT vs.
1LOF vs. 2LOF: 246(268), 316(189.50) and 493.5(423.25) respectively,
p=0.029]. Aspirin HPR (MEA ASPI ≥ 300 AU*min) made up 9.8% of
the population. Three patients (7.3%) had clopidogrel HPR (MEA ADP ≥
1 600 AU*min). All three plus another patient with borderline response
to clopidogrel, but had two LOF,were escalated to ticagrelor. All patients
had normal platelet reactivity upon discharge andwere alive at 30 days
but one patient developed recurrent NSTEMI. At 1 month, the cost of
POC-guided antiplatelet strategy for 41 patients was higher compared
to standard therapy (RM22,339.30 vs. RM16,528.90). At 1 year,
the cost of ticagrelor-for-all therapy, POC-guided therapy and
standard therapy, excluding major adverse cardiovascular events,
were RM118,326, RM30,171.60 and RM6,346.80 respectively.
Conclusion: POC-guided antiplatelet therapy is superior to standard
therapy in patients with Ml post PCI with DES, with only 1 MACE at
1-month post discharge. Additionally, there is substantial cost saving if
extrapolated to 1 year, compared to a ticagrelor-for-all therapy.
doi:10.1016/j.ijcard.2018.11.032
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Background: Aortic endothelium-dependent relaxation is im-
paired in diabetes mellitus. Malaysian propolis (MP) from stingless
bees (Heterotrigona itama) is polyphenol-rich resinous substance
that exhibits anti-hyperglycemic, antioxidative and cardioprotective
properties. However, vasomodulatory activity of MP has not been
investigated.
Objectives: This study aimed to determine the effect of MP
supplementation on aortic vascular reactivity in diabetic rats and its
mechanism of action.
Materials & methods:Male Sprague Dawley rats were divided into
four groups (n=6/group): normoglycemic control (NG), untreated
diabetes (DM), DM treated withmetformin (DM+Met, 300mg/kg/day)
and DM treated with MP (DM+MP, 300mg/kg/day). Induction of
type 1 DMwas performedwith intraperitoneal streptozotocin injection
(60mg/kg). Treatment by oral gavage was initiated immediately after
successful DM induction (fasting blood glucose N 11.1mM). After four
weeks, rats were euthanized, and thoracic aorta segments were
harvested for ex vivo tissue bath assay. Percentages relaxation of
phenylephrine-precontracted aortas to cumulative acetylcholine (10-8-
10-4 M) were recorded. For in vitro pharmacodynamics evaluation
of MP, thoracic aorta segments of normal rats (n=6/experiment)
were incubated with L-NAME (10-4M), methylene blue (10-5M),
indomethacin (10-5M) and elevated glucose (25mM), respectively,
for 30 minutes. Subsequently, relaxation responses to graded con-
centration of MP (0.01-1.00%) achieved by aortas precontracted with
phenylephrine were examined.
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